Browse by Title

Type here to filter the list

G
Glucagon-like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study

Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1655252###Presenting Author###Principal Researcher###Clinical Epidemiology Division, Karolinska Institutet###
Presenting Author: Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden ### 1062598###Co-Author###Research coordinator###Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
### @@@ Anders Hviid – Statens Serum Institut ### 1655991###Co-Author######Statens Serum Institut###
Co-Author: Anders Hviid – Statens Serum Institut
### @@@ Björn Eliasson – Sahlgrenska University Hospital ### 1655992###Co-Author######Sahlgrenska University Hospital###
Co-Author: Björn Eliasson – Sahlgrenska University Hospital
### @@@ Soffia Gudbjörnsdottir – University of Gothenburg ### 1655993###Co-Author######University of Gothenburg###
Co-Author: Soffia Gudbjörnsdottir – University of Gothenburg
### @@@ Christian Jonasson – Norwegian University of Science and Technology ### 1655995###Co-Author######Norwegian University of Science and Technology###
Co-Author: Christian Jonasson – Norwegian University of Science and Technology
### @@@ Kristian Hveem – Norwegian University of Science and Technology ### 1655994###Co-Author######Norwegian University of Science and Technology###
Co-Author: Kristian Hveem – Norwegian University of Science and Technology
### @@@ Henrik Svanström – Statens Serum Institut ### 2325204###Co-Author######Statens Serum Institut###
Co-Author: Henrik Svanström – Statens Serum Institut
### @@@ Mads Melbye – Danish Cancer Institute ### 2325205###Co-Author######Danish Cancer Institute###
Co-Author: Mads Melbye – Danish Cancer Institute
### @@@ Peter Ueda – Karolinska Institutet ### 2325206###Co-Author######Karolinska Institutet###
Co-Author: Peter Ueda – Karolinska Institutet
###
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan

Sarah M. Baxter, MPharm, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom ### 2325492###Presenting Author###Postdoctoral Research Fellow###Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom###
Presenting Author: Sarah M. Baxter, MPharm, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom
### she/her/hers @@@ Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1062545###Co-Author###Postdoctoral researcher###Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### he/him/his @@@ Jacob Harbo Andersen – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1360423###Co-Author######Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Jacob Harbo Andersen – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### @@@ Thomas Heiberg Brix – Department of Endocrinology, Odense University Hospital, Odense, Denmark ### 2325493###Co-Author######Department of Endocrinology, Odense University Hospital, Odense, Denmark###
Co-Author: Thomas Heiberg Brix – Department of Endocrinology, Odense University Hospital, Odense, Denmark
### @@@ Laszlo Hegedüs – Department of Endocrinology, Odense University Hospital, Odense, Denmark ### 2325494###Co-Author######Department of Endocrinology, Odense University Hospital, Odense, Denmark###
Co-Author: Laszlo Hegedüs – Department of Endocrinology, Odense University Hospital, Odense, Denmark
### @@@ Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Co-Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Chris Tzu-Ting Su – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325495###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Chris Tzu-Ting Su – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Co-Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Zoe Chi-Jui Chang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325498###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Zoe Chi-Jui Chang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Swaleh Hussain – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1991884###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Swaleh Hussain – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Cherry Chu, MSc – Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada ### 1659107###Co-Author######Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada###
Co-Author: Cherry Chu, MSc – Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada
### @@@ Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1359899###Co-Author###Scientist###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital ### 1660981###Co-Author###Scientist###Li Ka Shing Knowledge Institute, St. Michael’s Hospital###
Co-Author: Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital
### @@@ Antoine Eskander – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 2325500###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Antoine Eskander – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Zachary Bouck – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 2325501###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Zachary Bouck – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Co-Author###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 2325186###Co-Author###Postdoctoral fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1655650###Co-Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Karin Modig, MSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 1994660###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Karin Modig, MSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Mats Talbäck, BSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 2325502###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Mats Talbäck, BSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Rickard Ljung, MD, PhD, MPH – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 2325503###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Rickard Ljung, MD, PhD, MPH – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health ### 1360123###Co-Author######Norwegian Institute of Public Health###
Co-Author: Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health
### @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### @@@ Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland ### 1093536###Co-Author###Senior Lecturer###Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland###
Co-Author: Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###
Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
GP consultations for menstrual disorders after COVID-19 vaccination – a self-controlled cohort study based on routine healthcare data from the Netherlands

Rana Jajou, PhD – Netherlands Pharmacovigilance Centre Lareb ### 2325410###Co-Author###Epidemiologist###Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Rana Jajou, PhD – Netherlands Pharmacovigilance Centre Lareb
### @@@ Thomas Lieber – Netherlands Pharmacovigilance Centre Lareb ### 2325411###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Thomas Lieber – Netherlands Pharmacovigilance Centre Lareb
### @@@ Eugene P. Van Puijenbroek, MD, PhD (he/him/his) – Netherlands Pharmacovigilance Centre Lareb ### 1657307###Co-Author###senior advisor###Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Eugene P. Van Puijenbroek, MD, PhD (he/him/his) – Netherlands Pharmacovigilance Centre Lareb
### he/him/his @@@ Erik Mulder – Netherlands Pharmacovigilance Centre Lareb ### 2325412###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Erik Mulder – Netherlands Pharmacovigilance Centre Lareb
### @@@ Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research ### 1062554###Co-Author###Head of PHARMO Research###PHARMO Institute for Drug Outcomes Research###
Co-Author: Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Karin Hek – Netherlands institute for health services research (NIVEL) ### 1660077###Co-Author######Netherlands institute for health services research (NIVEL)###
Co-Author: Karin Hek – Netherlands institute for health services research (NIVEL)
### @@@ Florence P.A.M van Hunsel, PharmD, PhD – Netherlands Pharmacovigilance Centre Lareb ### 1062617###Presenting Author###Lead Safety Innovation###Netherlands Pharmacovigilance Centre Lareb###
Presenting Author: Florence P.A.M van Hunsel, PharmD, PhD – Netherlands Pharmacovigilance Centre Lareb
### @@@ Agnes Kant – Netherlands Pharmacovigilance Centre Lareb ### 1657352###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Agnes Kant – Netherlands Pharmacovigilance Centre Lareb
###
Growing Old Gracefully

Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences ### 1658378###Moderator###Senior Lecturer###School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences###
Moderator: Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences
### he/him/his @@@ Joan Forns, PhD – RTI Health Solutions ### 1062754###Moderator######RTI Health Solutions###
Moderator: Joan Forns, PhD – RTI Health Solutions
###